KTYCF (Kits Eyecare) ROCE %: 21.96% (As of Mar. 2026)


KTYCF Kits Eyecare Ltd KTYCF
74 GF Score
Price $8.86
GF Value $10.23
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Kits Eyecare ROCE %?

Kits Eyecare KTYCF -1.37% 74 ROCE % is 21.96% as of Mar. 2026. GuruFocus rates KTYCF with a GF Score™ of 74/100 and a GF Value™ of $10.23 (Modestly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Kits Eyecare's annualized ROCE % for the quarter that ended in Mar. 2026 was 21.96%.

Kits Eyecare  (OTCPK:KTYCF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Kits Eyecare ROCE % Related Terms

Kits Eyecare ROCE % Historical Data

* Premium members only.

The historical data trend for Kits Eyecare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kits Eyecare ROCE % Chart

Kits Eyecare Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial -36.84 -5.73 -2.02 8.61 8.81

Kits Eyecare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.12 -2.28 16.55 5.38 21.96
KTYCF
74GF Score
Kits Eyecare Ltd KTYCF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kits Eyecare ROCE % Calculation

Kits Eyecare's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=4.146/( ( (72.313 - 27.201) + (81.885 - 32.892) )/ 2 )
=4.146/( (45.112+48.993)/ 2 )
=4.146/47.0525
=8.81 %

Kits Eyecare's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=11.376/( ( (81.885 - 32.892) + (78.378 - 23.77) )/ 2 )
=11.376/( ( 48.993 + 54.608 )/ 2 )
=11.376/51.8005
=21.96 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 21.96% mean?
Kits Eyecare (KTYCF) has a ROCE % of 21.96% as of Mar. 2026.
Is Kits Eyecare's ROCE % too high?
Kits Eyecare's current ROCE % is 21.96%. The Retail - Cyclical industry median ROCE % is 7.58. Kits Eyecare's value of 21.96% is 189.7% above this industry median. Overall, Kits Eyecare has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kits Eyecare's ROCE % compare to CASY and WSM?
Kits Eyecare's ROCE % of 21.96% can be compared against companies in the Retail - Cyclical industry. The industry median ROCE % is 7.58. Kits Eyecare's value of 21.96% is 189.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Retail - Cyclical company?
The median ROCE % among Retail - Cyclical companies is 7.58, based on 1,117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kits Eyecare's current ROCE % of 21.96% is 189.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Retail - Cyclical industry, the median ROCE % is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kits Eyecare's current ROCE % is 21.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kits Eyecare stock overvalued right now?
Based on GuruFocus' analysis, Kits Eyecare (KTYCF) is currently considered Modestly Undervalued. The stock's GF Value™ is $10.23, compared to a current price of $8.86 — trading 13.4% below its estimated fair value. The current ROCE % is 21.96% and 189.7% above the Retail - Cyclical industry median of 7.58. Kits Eyecare's overall GF Score™ is 74/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Kits Eyecare (KTYCF), the current ROCE % is 21.96% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kits Eyecare (KTYCF) Overvalued in 2026?

Based on GuruFocus' analysis, Kits Eyecare stock appears to be undervalued. The current stock price of $8.86 is trading 13.4% below its estimated GF Value™ of $10.23. GuruFocus considers Kits Eyecare to be Modestly Undervalued.

Key valuation signals for KTYCF:

  • ROCE %: 21.96%
  • GF Value™: $10.23 vs. price of $8.86 (13.4% below fair value)
  • GF Score™: 74/100 with 1 warning sign
  • Industry Position: 189.7% above the Retail - Cyclical median

No single metric tells the full story. See the KTYCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kits Eyecare Business Description

Other Exchanges 0P3:GermanyKITS:Canada
Address 510 Seymour Street, Suite 1020, Vancouver, BC, CAN, V6B 3J5
Kits Eyecare Ltd is a vertically integrated, digitally native eyecare platform that offers its customers access to a vast selection of the highest quality contact lenses and eyeglasses, including its exclusive KITS-designed products, and a suite of online vision tools. It operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company's contact lens partners include Alcon, Bausch & Lomb, CooperVision, and Johnson & Johnson, and its glasses partners include Gucci, Oakley, Prive Revaux, Ray-Ban and Tom Ford. Its geographic locations are the United States; and Canada and Other which generates the majority of its revenue from the United States.
74GF Score

Get the complete analysis for KTYCF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.86
Price
$10.23
GF Value